Insurance Denials for Brand-Name Prescription Drugs Rose Sharply From 2018 to 2024
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the American Enterprise Institute found that insurance denials of first attempts to fill prescriptions for…
Read the full articleYou might also wanna read
Study: Climate change already causing $20 billion in annual crop losses, could reach $160 billion by 2100
newscientist.com·8h agoRutgers-Led Center Spots Emerging Tobacco Threats Years Faster Than Conventional Surveillance
Newswise·10h ago
Landmark Clinical Trial Results in First FDA-Approved Treatment for Rare Form of Obesity Caused by Brain Injury
Newswise·10h ago
CVD and Collaborators Launch Study to Better Understand Immune Responses to Lassa Fever
Newswise·11h ago
Research Tip Sheet: Cedars-Sinai Heart, Aging and Cancer Advances
Newswise·11h ago
Studying Viral Proteins on a Whole New Scale
Newswise·11h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.